Status:
COMPLETED
A Multisite Trial of ACQUIREc Therapy
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Hemiparetic Cerebral Palsy
Eligibility:
All Genders
3-8 years
Phase:
NA
Brief Summary
A multisite trial to testing different dosage levels of a systematic form of Pediatric Constraint-Induced (CI) Therapy called ACQUIREc Therapy. The high dosage treatment involved 6 hours of daily ther...
Eligibility Criteria
Inclusion
- Children 3-6 years of age
- Hemiparetic CP
Exclusion
- No prior CI therapy treatments
- No Botox for 6-months
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00991692
Start Date
June 1 2008
End Date
October 1 2009
Last Update
October 8 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35124